Oman Investment Authority (OIA), the sultanate’s sovereign wealth fund, has invested in Elon Musk’s brain-chip startup Neuralink as part of its strategy to expand its global portfolio through investments in advanced medical technologies and emerging sectors.

The fund confirmed the investment on Wednesday but did not disclose its value.

Founded in 2016 by Musk and headquartered in the United States, Neuralink develops implantable neural devices designed to create direct communication pathways between the human brain and digital systems. The technology is being developed to help address complex neurological conditions, including stroke and amyotrophic lateral sclerosis (ALS).

Neuralink has continued to advance its clinical ambitions, confirming earlier this year that neural devices have been implanted in 21 patients. It aims to perform 1,000 implant procedures by the end of the year.

The investment marks another step in OIA’s growing focus on future-facing technologies and follows its December 2024 investment in xAI, Musk’s artificial intelligence company.

OIA is also a shareholder in SpaceX, Musk’s aerospace firm known for its Starlink satellite communications network, underscoring the sovereign fund’s broader strategy of building exposure to high-growth technology sectors globally.

The latest move reflects a wider trend among Gulf sovereign wealth funds to diversify beyond traditional sectors and increase exposure to emerging technologies, including artificial intelligence, healthcare innovation, and advanced digital infrastructure.